DK31093D0 - - Google Patents

Info

Publication number
DK31093D0
DK31093D0 DK93310A DK31093A DK31093D0 DK 31093 D0 DK31093 D0 DK 31093D0 DK 93310 A DK93310 A DK 93310A DK 31093 A DK31093 A DK 31093A DK 31093 D0 DK31093 D0 DK 31093D0
Authority
DK
Denmark
Application number
DK93310A
Other languages
Danish (da)
Inventor
Poul Jacobsen
Flemming Elmelund Nielsen
Lone Jeppesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK93310A priority Critical patent/DK31093D0/da
Publication of DK31093D0 publication Critical patent/DK31093D0/da
Priority to HU9502726A priority patent/HUT73419A/hu
Priority to PCT/DK1994/000077 priority patent/WO1994021639A1/en
Priority to JP6520538A priority patent/JPH08507536A/ja
Priority to AU62018/94A priority patent/AU685783B2/en
Priority to EP94908979A priority patent/EP0691969A1/en
Priority to KR1019950703970A priority patent/KR100313051B1/ko
Priority to CA002158545A priority patent/CA2158545A1/en
Priority to CN94191979A priority patent/CN1041930C/zh
Priority to NZ262365A priority patent/NZ262365A/en
Priority to TW083101703A priority patent/TW304195B/zh
Priority to IL108800A priority patent/IL108800A/en
Priority to ZA941926A priority patent/ZA941926B/xx
Priority to US08/350,744 priority patent/US5559106A/en
Priority to FI954386A priority patent/FI954386A0/fi
Priority to NO953673A priority patent/NO305286B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK93310A 1993-02-19 1993-03-19 DK31093D0 (hu)

Priority Applications (16)

Application Number Priority Date Filing Date Title
DK93310A DK31093D0 (hu) 1993-03-19 1993-03-19
NZ262365A NZ262365A (en) 1993-03-19 1994-02-25 [1,2,4]triazolo[4,3-a]quinoxaline-4(5h)-one derivatives
KR1019950703970A KR100313051B1 (ko) 1993-03-19 1994-02-25 (1,2,4)트리아졸로(4,3-a)퀴녹살린유도체,이의제조방법및이를포함하는약제학적조성물
CN94191979A CN1041930C (zh) 1993-03-19 1994-02-25 [1,2,4]三唑并[4,3－a]喹喔啉衍生物,其制备及用途
JP6520538A JPH08507536A (ja) 1993-03-19 1994-02-25 〔１，２，４〕トリアゾロ〔４，３−ａ〕キノキサリン誘導体、それらの製造及び使用
AU62018/94A AU685783B2 (en) 1993-03-19 1994-02-25 (1,2,4) triazolo (4,3-a) quinoxaline derivatives, their preparation and use
EP94908979A EP0691969A1 (en) 1993-03-19 1994-02-25 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE
HU9502726A HUT73419A (en) 1993-03-19 1994-02-25 Process for preparing [1,2,4]triazolo[4,3-a]quinoxaline derivatives and pharmaceutical compositions containing them
CA002158545A CA2158545A1 (en) 1993-02-19 1994-02-25 [1,2,4,]triazolo[4,3-a]quinaxoline derivatives, their preparation and use
PCT/DK1994/000077 WO1994021639A1 (en) 1993-03-19 1994-02-25 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE
TW083101703A TW304195B (hu) 1993-03-19 1994-02-28
IL108800A IL108800A (en) 1993-03-19 1994-03-01 1-Transformed History of 4,5-Dihydro-1,2,4 [-Triazolo] A-3, 4 [Quinoxaline-4- On Preparation and Pharmaceutical Preparations Containing Them
ZA941926A ZA941926B (en) 1993-03-19 1994-03-18 Heterocyclic compounds their preparation and use
US08/350,744 US5559106A (en) 1993-03-19 1994-12-07 Heterocyclic compounds, their use and preparation
FI954386A FI954386A0 (fi) 1993-03-19 1995-09-18 (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö
NO953673A NO305286B1 (no) 1993-03-19 1995-09-18 Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93310A DK31093D0 (hu) 1993-03-19 1993-03-19

Publications (1)

Publication Number Publication Date
DK31093D0 true DK31093D0 (hu) 1993-03-19

Family

ID=8092112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93310A DK31093D0 (hu) 1993-02-19 1993-03-19

Country Status (16)

Country Link
US (1) US5559106A (hu)
EP (1) EP0691969A1 (hu)
JP (1) JPH08507536A (hu)
KR (1) KR100313051B1 (hu)
CN (1) CN1041930C (hu)
AU (1) AU685783B2 (hu)
CA (1) CA2158545A1 (hu)
DK (1) DK31093D0 (hu)
FI (1) FI954386A0 (hu)
HU (1) HUT73419A (hu)
IL (1) IL108800A (hu)
NO (1) NO305286B1 (hu)
NZ (1) NZ262365A (hu)
TW (1) TW304195B (hu)
WO (1) WO1994021639A1 (hu)
ZA (1) ZA941926B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
ATE190616T1 (de) * 1994-09-16 2000-04-15 Novo Nordisk As (1,2,4)triazolo(4,3-a)chinoxylinonderivate, ihre darstellung und verwendung als antagonisten von ampa-rezeptoren
JPH10506620A (ja) * 1994-09-16 1998-06-30 ノボ ノルディスク アクティーゼルスカブ 〔１，２，４〕トリアゾロ〔４，３−ａ〕キノキサリノン誘導体、それらの調製方法及び使用
US5679680A (en) * 1995-02-16 1997-10-21 Warner-Lambert Company α-substituted hydrazides having calpain inhibitory activity
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
WO1999024434A1 (en) 1997-11-11 1999-05-20 Ono Pharmaceutical Co., Ltd. Fused pyrazine compounds
AU2298399A (en) * 1998-02-06 1999-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Novel azapeptide type hydroxamic acid derivatives
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
AU2010219598A1 (en) 2009-03-05 2011-09-22 Astellas Pharma Inc. Quinoxaline compounds
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
CA2810659A1 (en) 2010-09-07 2012-03-15 Astellas Pharma Inc. Quinoxaline compound
EP2723744B1 (en) * 2011-06-27 2016-03-23 Janssen Pharmaceutica, N.V. 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
ES2855575T3 (es) 2012-06-26 2021-09-23 Janssen Pharmaceutica Nv Combinaciones que comprenden compuestos de 4-metil-[1,2,4]triazolo[4,3-a]quinoxalina como inhibidores de PDE2 e inhibidores de PDE10 para su uso en el tratamiento de trastornos neurológicos o metabólicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US4547501A (en) * 1983-09-02 1985-10-15 Pfizer Inc. Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
AU3767793A (en) * 1992-04-03 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
IL108800A (en) 1998-02-22
KR100313051B1 (ko) 2002-02-28
HU9502726D0 (en) 1995-11-28
IL108800A0 (en) 1994-06-24
AU685783B2 (en) 1998-01-29
EP0691969A1 (en) 1996-01-17
US5559106A (en) 1996-09-24
CN1041930C (zh) 1999-02-03
ZA941926B (en) 1995-09-18
TW304195B (hu) 1997-05-01
NO953673D0 (no) 1995-09-18
WO1994021639A1 (en) 1994-09-29
CN1122601A (zh) 1996-05-15
NO305286B1 (no) 1999-05-03
HUT73419A (en) 1996-07-29
JPH08507536A (ja) 1996-08-13
FI954386A (fi) 1995-09-18
FI954386A0 (fi) 1995-09-18
NZ262365A (en) 1997-05-26
NO953673L (no) 1995-11-17
KR960701057A (ko) 1996-02-24
CA2158545A1 (en) 1994-09-29
AU6201894A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
FR2702022B1 (hu)
FR2706747B1 (hu)
EP0779577A3 (hu)
DK31093D0 (hu)
EP0731715A4 (hu)
FR2706801B1 (hu)
FR2706803B1 (hu)
EP0661322A3 (hu)
FR2706827B1 (hu)
DK0611736T3 (hu)
FR2706856B1 (hu)
FR2706926B1 (hu)
EP0641839A3 (hu)
FR2706894B1 (hu)
FR2706865B1 (hu)
IN178572B (hu)
IN186798B (hu)
FR2706940B1 (hu)
IN186252B (hu)
IN185655B (hu)
IN174539B (hu)
ECSDI930096S (hu)
IN180018B (hu)
IN180122B (hu)
IN178335B (hu)

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment